SteadyTrade Treats π Adjusting Your Expectations π οΈ
SteadyTrade
SteadyTrade.com
4.6 β’ 589 Ratings
ποΈ 10 August 2020
β±οΈ 12 minutes
ποΈ Recording | iTunes | RSS
π§ΎοΈ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Good morning, steady trade treats listeners. |
| 0:03.0 | We are back for Monday's edition of your favorite treats of the week. |
| 0:08.0 | As you know, I'm Bryce Tooie, joined by Matthew Monica, and we're talking about penny stocks |
| 0:13.0 | and the overall market condition of these stocks. |
| 0:15.0 | And guys, we're not going to lie to you, it's slowing down a little bit. |
| 0:18.0 | I actually left earlier this past Friday. |
| 0:20.0 | I didn't see a whole lot I liked and, you know, it's better to, better to not make any money than to lose money. And I know I'll lose money in the slow market. But so we really, right now we have two stocks we want to talk about that we saw moving on Friday that we think could have some potential for Monday. And again, remember, this is not investment advice, only for informational, educational purposes. First stock we're going to talk about, and it's |
| 0:41.0 | one we talked about on Friday's episode, was RLFTF or Leaf Therapeutics Holding. The reason I |
| 0:47.4 | think this, and Matt and I were talking about, this is a good one to talk about is because it |
| 0:51.5 | had that red day, but it really wasn't a red day. |
| 0:55.3 | Like, it didn't, that wasn't there, there was no true panic. |
| 0:58.6 | There's really no new news on this yet. |
| 1:00.0 | But if they put on another PR here, or maybe even if they don't, I don't know, this, this could, this could fly. |
| 1:07.6 | So again, RLFF, the whole, the news that started this all off was that the FDA granted an |
| 1:13.6 | inhaled use for their RLF 100, which is eviptidol. I'm going to, that's going to be the word for it. |
| 1:21.2 | That's going to be what we call it here. To treat patients with moderate and severe COVID-19 |
| 1:24.5 | aiming to prevent progression to respiratory failure. Again, phase one |
| 1:29.1 | has not started up this testing yet. It was just simply news that the FDA has allowed them to |
| 1:34.3 | start these phases. So it's an investigational drug, no results for the company, and this is up a ton. |
| 1:42.0 | It started its run at, well, it opened up at five, five cents a share hit a high |
| 1:48.2 | on Thursday of 95 cents a share. And it did dip down into the mid 50 cents of share area, but closed, |
| 1:54.7 | I think it closed above 60. So there was, there was just no real panic. But Matt, you know these |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from SteadyTrade.com, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of SteadyTrade.com and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright Β© Tapesearch 2026.

